Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory reaction inside the eye.

Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in ...

Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient ...

Q1 2025 Management View CEO Brent Saunders highlighted that the company delivered mid-single-digit constant currency revenue growth in Q1 2025, with all three reporting segments showing positive ...

When cataract eye surgery is performed, the cloudy natural lens of the eye is removed, and a new intraocular lens, or IOL, is implanted to focus light properly and correct vision. The good news is ...

The indications for intraocular lens removal can occur during intraocular lens implantation or late postoperatively. These indications can be classified into four major categories: intraocular ...

An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the ...

New phakic IOLs are available or on the way ... They are a safer option compared with refractive lens exchange, which is known to put myopic eyes at high risk for retinal detachment.

Gregory Moloney, FRANZCO, FRCSC, presented a straightforward but impactful study evaluating a design modification in the ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.